Status:
COMPLETED
The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function
Lead Sponsor:
Northumbria University
Collaborating Sponsors:
Cherry Marketing Institute
Conditions:
Cardiometabolic Risk Factors
Cognitive Function
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
A randomized, double blind, counterbalanced, placebo controlled independent groups design to determine the effects of 3 month supplementation with tart cherry concentrate on indices of cardiometabolic...
Eligibility Criteria
Inclusion
- Healthy individuals between the ages of 40-60 years
- consume on average ≤5 servings of fruits and vegetables per day
- additionally have ≥1 risk factor for type 2 diabetes
Exclusion
- not regularly taking medication (or stabilised ≥ 3 months, with no adverse symptoms) or antioxidant supplements
- history of cardiometabolic, gastointestinal disease or malabsorption syndromes
- stage 2 hypertension (SBP \>159 mm Hg or DBP \>99 mm Hg)
- individuals who report changes in dietary or physical activity patterns within 3 months
- vegetarians, vegans or known eating disorders
- alcohol intake of more than 21 units per week
- BMI ≥40 kg/m2
- are pregnant or planning to become pregnant during the study, lactating, or initiating or changing a hormone replacement therapy regimen within 3 months of the start of the study
Key Trial Info
Start Date :
October 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04021342
Start Date
October 12 2018
End Date
February 29 2020
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northumbria University
Newcastle upon Tyne, United Kingdom, NE18ST